Age Dependend Diagnostic Thresholds for Osteoporosis Bindex Ultrasonometer
2 other identifiers
observational
560
1 country
1
Brief Summary
This study is designed for clinical validation of the novel ultrasound device (Bindex®, Bone Index Finland Ltd.). In a preliminary study technique has been validated in Finnish elderly woman population with 285 healthy and 56 osteoporotic subjects (n = 341 in total). Significant and good correlation was observed between Density Index (DI) determined with Bindex and femoral bone mineral density determined with DXA (r = 0.65 - 0.70). In addition, with determination of 90% sensitivity and specificity thresholds, significant number (65-75%) of patients could be diagnosed without additional verification with DXA. First, the thresholds for DI will be determined by measuring 70 osteoporotic and 70 healthy patients (n = 140) with Bindex and DXA within four decades of age; age 50 to 59 years, age 60 to 69 years, age 70 to 79 years, and age 80 to 89 years. The feasibility of DI for diagnostics of osteoporosis and evaluation of bone mineral density (BMD) will be assessed. The thresholds for the BMD estimate obtained with DI will be determined for osteoporotic and non-osteoporotic patients. For fracture risk assessment, DI measurements are used to predict the outcome of currently available fracture risk assessment tools.
- 1.To investigate optimal configuration of ultrasound parameters and patient characteristics for prediction of proximal femur and lumbar spine BMD for women in each four decades of age; 50 to 59 years, 60 to 69 years, 70 to 79 years, and 80-89 years.
- 2.To develop national diagnostic thresholds for DI in prediction of osteoporosis status with a reference female population (American-Caucasian) in each four decades of age; 50 to 59 years, 60 to 69 years, 70 to 79 years, and 80-89 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 28, 2013
CompletedFirst Posted
Study publicly available on registry
November 8, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2014
CompletedJanuary 29, 2015
January 1, 2015
1 year
October 28, 2013
January 28, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Thresholds for Bindex in Osteoporosis Diagnostics
Diagnostics thresholds for DI parameter for Osteoporosis within four decades of age; age 50 to 59 years, age 60 to 69 years, age 70 to 79 years, and age 80 to 89 years.
1 year
Eligibility Criteria
Female (American-Caucasian)
You may qualify if:
- Female sex
- Age 50 to 89 years
You may not qualify if:
- Those who have opted out of being contacted for research on their general Park Nicollet clinic consent will not be recruited by mail
- Inability to sign consent form due to cognitive impairment. Those with dementia (ICD-9 diagnosis codes 331.0, 294.1, 294.10, 294.11, or 294.8) will excluded from mailed recruitment
- Measurement of hip BMD is not feasible (for example, those who have had bilateral hip replacement surgeries or who cannot have central DXA because of their body weight)
- Open leg or arm wounds at sites where ultrasound measurements are supposed to be taken, precluding such measurements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bone Index Finland Ltdlead
- HealthPartners Institutecollaborator
Study Sites (1)
Park Nicollet Institute
Minneapolis, Minnesota, 55416, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John T Schousboe, MD, PhD
HealthPartners Institute
- STUDY DIRECTOR
Janne P Karjalainen, PhD
Bone Index Finland Ltd
- STUDY DIRECTOR
Ossi Riekkinen, PhD
Bone Index Finland Ltd
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 28, 2013
First Posted
November 8, 2013
Study Start
October 1, 2013
Primary Completion
October 1, 2014
Study Completion
October 1, 2014
Last Updated
January 29, 2015
Record last verified: 2015-01